Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis

被引:29
作者
Liu, Ning [1 ]
Wang, Zhen [1 ]
Gan, Weidong [1 ]
Xiong, Lei [1 ]
Miao, Baolei [1 ]
Chen, Xiancheng [1 ]
Guo, Hongqian [1 ]
Li, Dongmei [2 ,3 ,4 ]
机构
[1] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Urol,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Sch Med, Immunol & Reprod Biol Lab, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Univ, Sch Med, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
TRANSCRIPTION FACTOR E3; SOFT PART SARCOMA; BREAK-APART FISH; CLINICOPATHOLOGICAL FEATURES; TFE3; IMMUNOHISTOCHEMISTRY; EXPERIENCE; DIAGNOSIS; IMPACT; ADULTS;
D O I
10.1371/journal.pone.0166897
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To investigate the clinical characteristics, treatments and prognosis of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions (Xp11.2 tRCC), the epidemiological features and treatment results of 34 cases of Xp11.2 tRCC, which were diagnosed by immunohistochemistry staining of TFE3 and fluorescence in situ hybridization at our center, were retrospectively reviewed. The 34 patients included 21 females and 13 males aged 3 to 64 years (median age: 27 years). Four patients were children or adolescents (<18 years of age), and 26 patients were young or middle-aged adults (18-45 years). Radical nephrectomy was performed on 25 patients. Laparoscopic nephron-sparing surgery was performed on 9 patients who presented with an isolated mass with a small diameter (<7 cm) and well-defined boundary on computed tomography imaging. Postoperative staging showed that 25 cases (73.53%) were at stage I/II, while 9 cases (26.47%) were at stage III/IV. All stage I/II patients received a favorable prognosis with a three-year overall survival rate of 100%, including the patients who underwent laparoscopic nephron-sparing surgery. With the exception of 2 children, the other 7 stage III/IV patients died or developed recurrence with a median follow-up of 29 months. On univariate analysis, maximum diameter, adjuvant treatment, TNM stage, lymph node metastasis, inferior vena cava tumor thrombosis and tumor boundary were identified as statistically significant factors impacting survival (P<0.05). Multivariate analysis indicated that TNM stage and inferior vena cava tumor thrombosis were independent prognostic factors (P<0.05). In conclusion, Xp11.2 tRCC is a rare subtype of renal cell carcinoma that mainly occurs in young females. Nephron-sparing surgery was confirmed effective preliminarily in the treatment of small Xp11.2 tRCCs with clear rims. Advanced TNM stage and inferior vena cava tumor thrombosis were associated with poor prognosis.
引用
收藏
页数:13
相关论文
共 36 条
[1]  
[Anonymous], 2016, WHO classification of tumours of the urinary system and male genital organs
[2]  
[Anonymous], 2004, PATHOLOGY GENETICS T
[3]  
[Anonymous], MEDICINE
[4]   Renal carcinomas with the t(6;11)(p21;q12) -: Clinicopathologic features and demonstration of the specific Alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR [J].
Argani, P ;
Laé, M ;
Hutchinson, B ;
Reuter, VE ;
Collins, MH ;
Perentesis, J ;
Tomaszewski, JE ;
Brooks, JSJ ;
Acs, G ;
Bridge, JA ;
Vargas, SO ;
Davis, IJ ;
Fisher, DE ;
Ladanyi, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (02) :230-240
[5]   PRCC-TFE3 renal carcinomas -: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21) [J].
Argani, P ;
Antonescu, CR ;
Couturier, J ;
Fournet, JC ;
Sciot, R ;
Debiec-Rychter, M ;
Hutchinson, B ;
Reuter, VE ;
Boccon-Gibod, L ;
Timmons, C ;
Hafez, N ;
Ladanyi, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (12) :1553-1566
[6]   Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma -: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents [J].
Argani, P ;
Antonescu, CR ;
Illei, PB ;
Lui, MY ;
Timmons, CF ;
Newbury, R ;
Reuter, VE ;
Garvin, AJ ;
Perez-Atayde, AR ;
Fletcher, JA ;
Beckwith, JB ;
Bridge, JA ;
Ladanyi, M .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :179-192
[7]   Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum [J].
Argani, Pedram ;
Olgac, Semra ;
Tickoo, Satish K. ;
Goldfischer, Michael ;
Moch, Holger ;
Chan, David Y. ;
Eble, John N. ;
Bonsib, Stephen M. ;
Jimeno, Mireya ;
Lloreta, Josep ;
Billis, Athanase ;
Hicks, Jessica ;
De Marzo, Angelo M. ;
Reuter, Victor E. ;
Ladanyi, Marc .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (08) :1149-1160
[8]   Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: Progression and long-term survival [J].
Carini, M ;
Minervini, A ;
Lapini, A ;
Masieri, L ;
Serni, S .
JOURNAL OF UROLOGY, 2006, 175 (06) :2022-2026
[9]  
Chen Xiancheng, 2014, Zhonghua Yi Xue Za Zhi, V94, P3675
[10]  
Cheng XM, 2015, INT J CLIN EXP PATHO, V8, P5403